CGS 8216 and CGS 9896, novel pyrazoloquinoline benzodiazepine ligands with benzodiazepine agonist and antagonist properties
- 31 October 1985
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 23 (4), 639-644
- https://doi.org/10.1016/0091-3057(85)90431-9
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Evaluation of the ?-carboline ZK 93 426 as a benzodiazepine receptor antagonistPsychopharmacology, 1984
- CGS 9896: A nonbenzodiazepine, nonsedating potential anxiolyticDrug Development Research, 1984
- The neuropharmacology of various diazepam antagonistsNeuropharmacology, 1983
- Interactions of ethyl-β-carboline-3-carboxylate and Ro 15-1788 with CGS 8216 in an animal model of anxietyNeuroscience Letters, 1983
- Quinolines and anxiety: Anxiogenic effects of CGS 8216 and partial anxiolytic profile of PK 9084Pharmacology Biochemistry and Behavior, 1983
- Photoaffinity labelling of the benzodiazepine receptor cannot be used to predict ligand efficacyNeuroscience Letters, 1983
- A novel pyrazoloquinoline that interacts with brain benzodiazepine receptors: Characterization of some and properties of CGS 9896.Life Sciences, 1982
- Anxiolytic drugs selectively increase preferred duration of rewarding brain stimulation in a shuttlebox testPharmacology Biochemistry and Behavior, 1982
- CGS 8216: Receptor binding characteristics of a potent benzodiazepine antagonistLife Sciences, 1982
- Multiple benzodiazepine receptors and their regulation by γ-aminobutyricLife Sciences, 1981